Distinct patterns of expression of keratinocyte growth factor and its receptor in endometrial carcinoma

Cancer

Volumn 79, Issue 6, 1997, Pages 1166-1171

  Siegfried, Sari ^a,b   Pekonen, Fredrika ^a   Nyman, Tuulikki ^a   Ämmälä, Martti ^a   Rutanen, Eeva Marja ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

carcinosarcoma; endometrial adenocarcinoma; fibroblast growth factor receptor 2 (FGFR 2); keratinocyte growth factor (KGF); keratinocyte growth factor receptor (KGFR)

Indexed keywords

ACTIN; COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; CARCINOSARCOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOUTHERN BLOTTING;

ADENOCARCINOMA; AGED; CARCINOSARCOMA; ENDOMETRIAL NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GENE AMPLIFICATION; GROWTH SUBSTANCES; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0030894026     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970315)79:6<1166::AID-CNCR15>3.0.CO;2-Y     Document Type: Article

References (22)

1. Bishop JM. The molecular genetics of cancer. Science 1987;235:305-11.
2. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989;245:725-52.
3. Parrott JA, Vigne J-L, Chu BZ, Skinner MK. Mesenchymal-epithelial interactions in the ovarian follicle involve keratinocyte and hepatocyte growth factor production by thecal cells and their action on granulosa cells. Endocrinology 1994;135:569-75.
4. Pekonen F, Nyman T, Rutanen E-M. Differential expression of keratinocyte growth factor and its receptor in the human uterus. Mol Cell Endocrinol 1993;95:43-9.
5. Koji T, Chedid M, Rubin JS, Slayden OD, Csaky KG, Aaronson SA. Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as progestomedin. J Cell Biol 1994;125:393-401.
6. Siegfried S, Pekonen F, Nyman T, Ämmälä M. Expression of mRNA for keratinocyte growth factor and its receptor in human endometrium. Acta Obstet Gynecol Scand 1995; 74:410-4.
7. Van G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan WL. Heparin-binding keratinocyte growth factor is candidate stromal to epithelial andromedin. Mol Endocrinol 1992;6:2123-8.
8. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, et al. Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 1994;91:1074-8.
9. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AML, et al. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 1992; 89:246-50.
10. Gurpide E. Endometrial cancer: biochemical and clinical correlates. J Natl Cancer Inst 1991;83:405-16.
11. Simon D, Heyner S, Satyaswaroop PG, Farber M, Noumoff JS. Is chromosome 10 a primary chromosomal abnormality in endometrial adenocarcinoma. Cancer Genet Cytogenet 1990;47:155-62.
12. Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein M, Dunne ME, et al. Uterine sarcomas. Natural history, treatment and prognosis. Cancer 1978;42:1152-60.
13. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
15. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, et al. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 1990;9:2685-92.
16. Ponte P, Ng S-Y, Engel J, Gunning P, Kedes L. Evolutionary coservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984;12:1687-93.
17. Peters WA, Kumar NB, Fleming WP, Morley GW. Prognostic features of sarcomas and mixed tumors of the endometrium. Obstet Gynecol 1984;63:550-6.
18. Bergeron C, Ferenczy A, Shyamala G. Distribution of estrogen receptors in various cell types of normal, hyperplastic, and neoplastic human endometrial tissues. Lab Invest 1988;58:338-45.
19. Berchuck A, Soisson AP, Olt GJ, Soper JT, Clarke-Pearson DL, Bast RC, et al. Epidermal growth factor receptor in normal and malignant endometrium. Am J Obstet Gynecol 1989;161:1247-52.
20. Aaro LA, Symmonds RE, Dockerty MB. Sarcoma of the uterus. A clinical and pathologic study of 177 cases. Am J Obstet Gynecol 1966;94:101-9.
21. Ishii H, Hattori Y, Itoh H, Kishi T, Yoshida T, Sakamoto H, et al. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines. Cancer Res 1994;54:518-22.
22. Kraus MH, Pierce JH, Fleming TP, Robbins KC, Di Fiore PP, Aaronson SA. Mechanisms by which genes encoding growth factors and growth factor receptors contribute to malignant transformation. Ann NY Acad Sci 1988;551:320-35.